Skip to main content

Leukemia and lymphoma

Publication ,  Journal Article
Kelsey, CR; Kim, GJ
Published in: Medical Radiology
January 1, 2017

Leukemias and lymphomas comprise a diverse collection of malignancies with unique clinical behavior. Radiation therapy plays an integral role in the definitive, adjuvant, and palliative management of these hematologic malignancies. As opposed to most epithelial and mesenchymal malignancies, hematologic malignancies typically require lower doses of radiation therapy. Most can be controlled with 24–40 Gy, well within the tolerance of most normal tissues. In the palliative setting, exceptionally low doses (e.g., 4 Gy) are often sufficient. This characteristic of hematologic malignancies allows for re-treatment, when necessary, in most circumstances. In this chapter, we will review the major histologic subtypes of hematologic malignancies and discuss the settings where re-irradiation is sometimes encountered in clinical practice.

Duke Scholars

Published In

Medical Radiology

DOI

EISSN

2197-4187

ISSN

0942-5373

Publication Date

January 1, 2017
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kelsey, C. R., & Kim, G. J. (2017). Leukemia and lymphoma. Medical Radiology. https://doi.org/10.1007/174_2016_32
Kelsey, C. R., and G. J. Kim. “Leukemia and lymphoma.” Medical Radiology, January 1, 2017. https://doi.org/10.1007/174_2016_32.
Kelsey CR, Kim GJ. Leukemia and lymphoma. Medical Radiology. 2017 Jan 1;
Kelsey, C. R., and G. J. Kim. “Leukemia and lymphoma.” Medical Radiology, Jan. 2017. Scopus, doi:10.1007/174_2016_32.
Kelsey CR, Kim GJ. Leukemia and lymphoma. Medical Radiology. 2017 Jan 1;

Published In

Medical Radiology

DOI

EISSN

2197-4187

ISSN

0942-5373

Publication Date

January 1, 2017